Literature DB >> 2668007

Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.

F D Juma1, J O Ogeto.   

Abstract

Mefloquine pharmacokinetics were studied in Kenyan African normal volunteers and in patients with severe acute attack of Plasmodium falciparum malaria. Peak concentrations were achieved in both groups at 20-24 hours. The mean half-life of elimination was 385 +/- 150 hours (mean +/- SD) in normal subjects while in severe malaria it was 493 +/- 215 hours which was significantly longer (P less than or equal to 0.001). The volume of distribution was significantly smaller in severe malaria where it was 30.76 +/- 10.50 l/kg (mean +/- SD) while in the normal subjects it was 40.90 +/- 20.70 l/kg (mean +/- SD) (P less than or equal to 0.001). The total body clearance in severe malaria was 3.75 +/- 1.51 l/h (mean +/- SD). This was significantly lower than in the normal subjects where it was 5.15 +/- 1.50 l/h (mean +/- SD) (P less than or equal to 0.001).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668007     DOI: 10.1007/BF03190836

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  Quantitation of the antimalarial agent, mefloquine, in blood, plasma, and urine using high-pressure liquid chromatography.

Authors:  J M Grindel; P F Tilton; R D Shaffer
Journal:  J Pharm Sci       Date:  1977-06       Impact factor: 3.534

2.  Kinetics of a new antimalarial, mefloquine.

Authors:  R E Desjardins; C L Pamplin; J von Bredow; K G Barry; C J Canfield
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

3.  Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man.

Authors:  D E Schwartz; W Weber; D Richard-Lenoble; M Gentilini
Journal:  Acta Trop       Date:  1980-09       Impact factor: 3.112

4.  Practical therapeutics: treatment of complications of malaria.

Authors:  F D Juma
Journal:  East Afr Med J       Date:  1984-09

5.  Analysis of the antimalarial, mefloquine, in blood and plasma using high-performance liquid chromatography.

Authors:  I M Kapetanovic; J D DiGiovanni; J Bartosevich; V Melendez; J Von Bredow; M Heiffer
Journal:  J Chromatogr       Date:  1983-10-14

6.  The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.

Authors:  J H Rivière; D J Back; A M Breckenridge; R E Howells
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

7.  Development of mefloquine as an antimalarial drug. UNDP/World Bank/WHO update.

Authors: 
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

  7 in total
  10 in total

1.  Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study.

Authors:  F Nosten; J Karbwang; N J White; K Na Bangchang; D Bunnag; T Harinasuta
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

3.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

Review 4.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

5.  Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria.

Authors:  F Nosten; F ter Kuile; T Chongsuphajaisiddhi; K Na Bangchang; J Karbwang; N J White
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

6.  Pharmacokinetics and pharmacodynamics of mefloquine in Thai patients with acute falciparum malaria.

Authors:  J Karbwang; K N Bangchang; D Bunnag; T Harinasuta
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

7.  Whole blood concentrations of mefloquine enantiomers in healthy Thai volunteers.

Authors:  C Martin; F Gimenez; K N Bangchang; J Karbwang; I W Wainer; R Farinotti
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  Paracetamol disposition in Thai patients during and after treatment of falciparum malaria.

Authors:  S Ismail; K Na Bangchang; J Karbwang; D J Back; G Edwards
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 9.  The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review.

Authors:  Renée J Burger; Benjamin J Visser; Martin P Grobusch; Michèle van Vugt
Journal:  Malar J       Date:  2016-02-18       Impact factor: 2.979

10.  In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula).

Authors:  Aaron Michael Izes; Benjamin Kimble; Jacqueline Marie Norris; Merran Govendir
Journal:  PLoS One       Date:  2020-04-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.